dacomitinib (Vizimpro)

Indications

• investigational drug for treatment of lung cancer

Dosage

Tabs: 15,30, 45 mg

Mechanism of action

• inhibitor of the HER family of tyrosine kinases
• irreversibly binds to & inhibits human Her-1, Her-2, & Her-4,

More general terms

• small inhibitory antineoplastic agent (ib drug)

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=11511120
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=70693519